The sCD40L/CD40 pathway activation in gastric cancer inhibited Fas- and drug-dependent apoptosis and also increased the motility of CD40-positive cancer cells, thus facilitating the formation of metastases, what was confirmed in humans [54]. This evidence concerns the gene CD40LG and gastric cancer.